These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23592588)

  • 1. Challenges in patient selection for the parachute device implantation.
    Bozdag-Turan I; Bermaoui B; Paranskaya L; GökmenTuran R; D'Ancona G; Kische S; Birkemeyer R; Jovanovic B; Schuetz J; Akin I; Turan CH; Ortak J; Hauenstein K; Nienaber CA; Ince H
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E718-25. PubMed ID: 23592588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study.
    Costa MA; Mazzaferri EL; Sievert H; Abraham WT
    Circ Heart Fail; 2014 Sep; 7(5):752-8. PubMed ID: 25037310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial.
    Thomas M; Nienaber CA; Ince H; Erglis A; Vukcevic V; Schäfer U; Ferreira RC; Hardt S; Verheye S; Gama Ribeiro V; Sugeng L; Tamburino C
    EuroIntervention; 2015 Oct; 11(6):710-7. PubMed ID: 26499223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence for favourable effects on haemodynamics and ventricular performance after Parachute(®) implantation in humans.
    Schmidt T; Frerker C; Thielsen T; Dotz I; Wohlmuth P; Kuck KH; Schäfer U
    Eur J Heart Fail; 2014 Oct; 16(10):1112-9. PubMed ID: 25298333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left ventricular partitioning in patients with chronic heart failure and a prior anterior myocardial infarction: Results of the PercutAneous Ventricular RestorAtion in Chronic Heart failUre PaTiEnts Trial.
    Mazzaferri EL; Gradinac S; Sagic D; Otasevic P; Hasan AK; Goff TL; Sievert H; Wunderlich N; Nikolic SD; Abraham WT
    Am Heart J; 2012 May; 163(5):812-820.e1. PubMed ID: 22607859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac computed tomography assessment of the near term impact of percutaneous ventricular restoration therapy (parachute(®) ) on mitral valve geometry.
    Tam CC; Fares A; Alaiti A; Shaikh K; Ince H; Erglis A; Bezerra HG; Abraham WT; Costa MA; Attizzani GF
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):E45-51. PubMed ID: 26526037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PARACHUTE IV trial design and rationale: percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles.
    Costa MA; Pencina M; Nikolic S; Engels T; Templin B; Abraham WT
    Am Heart J; 2013 Apr; 165(4):531-6. PubMed ID: 23537969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous implantation of a left ventricular restoration device [Parachute(TM)] for the treatment of ischemic heart failure].
    Ielasi A; Tespili M; Repossini A; Scopelliti P; Paganoni S; Cafro A; Silvestro A; Personeni D; Saino A; Muneretto C
    G Ital Cardiol (Rome); 2015 Jan; 16(1):52-7. PubMed ID: 25689752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-man study of Heartech® percutaneous left ventricular partitioning device for treatment of heart failure postmyocardial infarction.
    Zhu Z; Yu J; Xu K; Tang Y; Fang Y; Gu J; Gu S; Ding F; Modine T; Zhang R
    Catheter Cardiovasc Interv; 2019 Nov; 94(6):845-853. PubMed ID: 31231944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous implantation of a ventricular partitioning device for treatment of ischemic heart failure: initial experience of a center.
    Silva G; Melica B; Pires de Morais G; Sousa O; Bettencourt N; Ribeiro J; Simões L; Gama V
    Rev Port Cardiol; 2012 Dec; 31(12):795-801. PubMed ID: 23159579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the quality of implantation of percutaneous ventricular restoration device (Parachute®) by cardiac computed tomography.
    Alaiti MA; Fares A; Erglis A; Nshisso L; Shaikh K; DeCicco AE; Nasif M; Alkhalil A; Ince H; Abraham WT; Simon DI; Costa MA; Attizzani GF; Bezerra HG
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E104-E111. PubMed ID: 27470983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study.
    Yang YJ; Huo Y; Xu YW; Wang JA; Han YL; Ge JB; Zhang RY; Yan XY; Gao RL
    Chin Med J (Engl); 2016 Sep; 129(17):2058-62. PubMed ID: 27569231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.
    Bertini M; Delgado V; Nucifora G; Marsan NA; Ng AC; Shanks M; Van Bommel RJ; Borleffs CJ; Ewe SH; Boriani G; Biffi M; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Sep; 106(5):682-7. PubMed ID: 20723646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heartech® left ventricular partitioning device improves left ventricular systolic function of patients with chronic heart failure post-myocardial infarction at 1-year follow-up.
    Su X; Yang W; Zhu Z; Zhang R; Fang Y
    Catheter Cardiovasc Interv; 2022 Jan; 99(1):50-56. PubMed ID: 33502092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis analysis of PARACHUTE device implantation in patients with ischemic heart failure: a single-center experience of Chinese patients.
    Li J; Liu H; Liu Q; Liu C; Xiong W; Ma W; Zhang B; Dong S; Li T
    J Cardiothorac Surg; 2021 Apr; 16(1):98. PubMed ID: 33879206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.